The Latest

SEARCH BY KEYWORD
BROWSE BY Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Healthcare IP Development Through Circles

Post
March 7, 2024
Many provider groups and product manufacturers recognize the inherent value of validated, well-structured datasets generated in the busy clinical setting. Meanwhile, independent practice groups are now in an equally strong position to develop and capture IP value through real-world evidence programs
Type image caption here (optional)Many provider groups and product manufacturers recognize the inherent value of validated, well-structured datasets generated in the busy clinical setting. (The FDA, payers and others refer to such datasets as real-world evidence.) A major category of thoughtfully-designed and executed real-world evidence programs is intellectual property – inventions, patents, trade secrets, and copyrights. Most large hospital systems now have “innovation centers”, “tech transfer departments” and similar units designed to generate license revenues. They generally fail, however, to tap into RWE, the richest source of such IP. Moreover, their revenue shares for clinician inventors, and complex IP processes, may often stifle rather than incentivize marketable inventions. Meanwhile, independent practice groups are now in an equally strong position to develop and capture IP value through real-world evidence programs. They can do so on their own, accumulating and curating fit-for-purpose RWE until its clinical significance warrants licensing and monetization. Alternatively, they can partner with product manufacturers in establishing an RWE program designed to maximize specific IP objectives from the beginning.In all cases, Circles represent a robust yet low-cost platform, with excellent user experience, for designing and implementing RWE programs leading to IP value. Contact us to learn more.
See more
Arrow right

Real-World Evidence Featured Prominently at this Year's IOF MAX!

Client News
February 7, 2024
The recent IOF MAX Experience, organized by the Interventional Orthobiologics Foundation, brought together some of the world’s foremost experts on orthobiologics to share their proprietary real-world data and real-world evidence.
Type image caption here (optional)The recent IOF MAX Experience, organized by the Interventional Orthobiologics Foundation, brought together some of the world’s foremost experts on orthobiologics to share their proprietary real-world data and real-world evidence. Many of those experts proudly included a growing number of Circle founders, including: ‍Peter A. Everts, PhD, FRSM opened the show with some nuanced hypotheses for "Where will the Field of Orthobiologics be in 2030?". Those same hypotheses informed his launch of the Gulf Coast Biologics Knee and Shoulder Circles over a year ago.Imran Siddiqui, Research Director at Regenerative Orthopedics & Sports Medicine, presented statistically significant 1 year results from those same Circles. Numerous IOF members joined Dr. Everts and Siddiqui as expert co-investigators, including: Luga Podesta, MD, Glenn M. Flanagan II, Alberto J. Panero D.O., Shounuck Patel, DO, Walter I. Sussman, Gayan Poovendran MD,CAQSM, and Ariana De Mers. Special thanks as well to Dr. Chris Brown Mahoney for her statistical analyses, which is a critical component for elevating real-world "data" into "evidence". Lastly, IOF members and sponsors continue to launch and grow their own real-world studies in 2024. We present their headshots and studies proudly, as their proprietary real-world evidence are bound to play a role in future curriculums, standards and regulatory decisions.Contact us to learn more about Circles.
See more
Arrow right

Circles Monetization Through Generative AI

Post
January 29, 2024
Generative AI (GAI) is considered the most important technical development since the establishment of the Internet. It has profound implications in healthcare. Research, product development, and clinical decision-making are a few major examples.
Generative AI (GAI) is considered the most important technical development since the establishment of the Internet. It has profound implications in healthcare. Research, product development, and clinical decision-making are a few major examples. At the same time, clinical-grade real-world data (RWD) is fast becoming the most important data category in healthcare. More than EMR, payer, RCT, and other types of data, RWD is essential to achieving value-based care, health equity and overall cost reduction in healthcare delivery. GAI/RWD use cases will include value-based care for payers, product development for manufacturers, scientific breakthroughs for researchers, and clinical decision support for providers. Circles represent proprietary and well-structured RWD databases which are ideal for a variety of GAI applications. They possess several important characteristics making them attractive for healthcare-related GAI applications: They are well-structured, enabling the efficient derivation of statistically significant correlations among scientific hypotheses, clinical interventions, and long-term outcomes. They are “fit-for-purpose”. Each Circle database corresponds to one or two well-defined endpoints representing clinically and statistically significant datasets. Data integrity, auditability, scalability, and regulatory compliance. Clear data ownership rights. Ease of integration with other private (e.g., EMR) or public (e.g., open access medical literature) data sources. Circles Founders and Members already capture value from their RWD through publication, study investigator fees, honoraria, and other channels. Their most important opportunity for value creation will likely come from Generative AI. For more information, see our Articles on the importance of real world data and Circles data monetization.
See more
Arrow right
Nothing was found. Please use a single word for precise results.
Stay Informed.
Subscribe for our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.